Clinical Trial Update: Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for DaxibotulinumtoxinA (DAXI) for injection show efficacy and safety in treating upper facial lines (glabellar, forehead, and la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Forehead Lines
• Glabellar Lines
• Lateral Canthal Lines
• Upper Facial Lines

Drugs mentioned

• DaxibotulinumtoxinA (DAXI) (daxibotulinumtoxinA)

Snippet

Sponsor: Revance Therapeutics, Inc. | Conditions: Upper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines) | Phase 2 | Status: COMPLETED | Results posted: 2023-06-27